BEHAVIORAL AND NEUROCHEMICAL RESPONSES TO HALOPERIDOL AND SCH-23390 IN RATS TREATED NEONATALLY OR AS ADULTS WITH 6-HYDROXYDOPAMINE
- 1 December 1987
- journal article
- research article
- Vol. 243 (3) , 1027-1034
Abstract
Behavioral and neurochemical effects of haloperidol (D2-dopamine antagonist) and SCH-23390 (D1-dopamine antagonist) were examined in unlesioned rats and in rats lesioned with 6-hydroxydopamine (6-OHDA) as adults or as neonates. In unlesioned rats, chronic haloperidol treatment (15 days) resulted in an increase in D2-dopamine receptor density, as measured with [3H]spiperone, in the nucleus accumbens and in the caudate-putamen. Rats treated as adults with 6-OHDA responded to chronic haloperidol similarly to controls. However, adult rats treated with 6-OHDA as neonates did not exhibit an increase in [3H]spiperone binding in response to chronic haloperidol treatment. Control and adult 6-OHDA-treated rats given haloperidol exhibited a profound akinesia. In contrast, rats that received 6-OHDA as neonates and were tested as adults did not display a significant behavioral response to haloperidol at doses as high as 2 mg/kg. Results similar to those for haloperidol were also found for SCH-23390. Chronic treatment (15 days) with this D1-dopamine antagonist increased [3H]SCH-23390 binding in the nucleus accumbens and caudate-putamen in unlesioned rats as well as in adult 6-OHDA-treated rats. However, after neonatal 6-OHDA treatment, an elevation in [3H]SCH-23390 binding did not occur after chronic SCH-23390 treatment. SCH-23390 produced akinesia similar to that produced by haloperidol in unlesioned and in adult 6-OHDA-treated rats. In contrast, rats lesioned with 6-OHDA as neonates and tested as adults did not exhibit a significant behavioral response to SCH-23390 under our test conditions. The results indicate that destruction of dopamine-containing neurons in neonates, but not in adults, is accompanied by neural adaptation that makes rats refractory to acute and chronic effects of D1- and D2-dopamine receptor blockade, providing further documentation for the hypothesis that the age at which dopamine-containing neurons are destroyed results in different adapative responses.This publication has 15 references indexed in Scilit:
- SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neuronsEuropean Journal of Pharmacology, 1985
- BEHAVIORAL-DIFFERENCES BETWEEN NEONATAL AND ADULT 6-HYDROXYDOPAMINE-TREATED RATS TO DOPAMINE AGONISTS - RELEVANCE TO NEUROLOGICAL SYMPTOMS IN CLINICAL SYNDROMES WITH REDUCED BRAIN DOPAMINE1984
- Biochemical Evidence of Dysfunction of Brain Neurotransmitters in the Lesch-Nyhan SyndromeNew England Journal of Medicine, 1981
- Simultaneous quantification of dopamine, 5-hydroxytryptaine and four metabolically related compounds by means of reversed-phase high-performance liquid chromatography with electrochemical detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Dopamine receptor changes following destruction of the nigrostriatal pathway: Lack of a relationship to rotational behaviorBrain Research, 1981
- The Woolf plot is more reliable than the Scatchard plot in analysing data from hormone receptor assaysJournal of Steroid Biochemistry, 1980
- Dopamine Receptor Binding Enhancement Accompanies Lesion-Induced Behavioral SupersensitivityScience, 1977
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977
- Effect of various 6-hydroxydopamine treatments during development on growth and ingestive behaviorPharmacology Biochemistry and Behavior, 1975
- A familial disorder of uric acid metabolism and central nervous system functionThe American Journal of Medicine, 1964